gimli
FABTECH stock analysis context

FABTECH TECHNOLOGIES Stock Context for AI Screening

FABTECH TECHNOLOGIES LTD is a small-cap stock in Healthcare. This page summarizes key screening signals for FABTECH TECHNOLOGIES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive FABTECH stock page
Price
₹152.06
1W return
-2.97%
1M return
-9.83%
3M return
+3.00%
6M return
-34.51%
1Y return
n/a
Market cap
₹675.92 cr
PE
13.02
PB
1.61
ROE
n/a
ROCE
n/a
RSI
45.01
Turnover
₹1.18 cr

Why it can matter in screens

Financials and Ownership

Quarterly income statement

PeriodRevenueEBITDAPATEPS
2026-03-31158.52 cr32.06 cr22.06 cr5.75
2025-12-3162.76 cr-4.50 cr-5.68 cr-1.56
2025-03-31134.86 cr21.65 cr15.09 cr3.39
2024-12-31104.32 cr24.62 cr20.46 cr4.60

Annual income statement

No recent data available.

Balance sheet

PeriodAssetsCashDebtEquity
2026-03-31653.70 cr86.88 cr69.63 cr419.77 cr
2025-03-31426.56 cr9.06 cr83.83 cr173.11 cr

Cash flow

PeriodOCFFCFCash change
2026-03-31n/an/an/a
2025-12-31n/an/an/a
2025-03-31n/an/an/a
2024-12-31n/an/an/a

Shareholding Trend

PeriodPromoterFII/FPIDIIMFRetailPledge
2026-03-31+68.94%+0.08%+2.15%+0.00%+28.83%+100.00%
2025-12-31+68.94%+0.03%+1.99%+0.00%+29.04%+100.00%
2025-10-06+68.94%+1.91%+11.63%+0.00%+17.52%+100.00%

Industry Peers

SymbolNameMcapPEROE1Y
SUNPHARMASUN PHARMACEUTICAL IND L429,121.06 cr40.824543+15.06%+7.26%
DIVISLABDIVI S LABORATORIES LTD174,585.42 cr68.707369+17.81%+0.71%
TORNTPHARMTORRENT PHARMACEUTICALS L147,849.87 cr68.354079+29.94%+39.35%
APOLLOHOSPAPOLLO HOSPITALS ENTER. L119,204.71 cr64.295958+23.21%+21.70%
CIPLACIPLA LTD111,088.72 cr29.624450+12.91%-6.65%
ZYDUSLIFEZYDUS LIFESCIENCES LTD108,331.15 cr21.874917+20.44%+16.21%
DRREDDYDR. REDDY S LABORATORIES105,181.70 cr24.542479+13.88%+1.20%
LUPINLUPIN LIMITED103,385.66 cr22.341869+29.22%+15.72%

Try these prompts

Related screen ideas

Data snapshot: 2026-06-03. Not investment advice.